Aveanna Healthcare Holdings, Inc. (AVAH) intrinsic value & 10-year financials
Aveanna Healthcare Holdings, Inc. (AVAH) has a Graham intrinsic value of $22.19 per share. At $12.34 on Oct 17, 2026, the stock trades 44% below that value. Over the last 7 fiscal years revenue grew 11.9% a year to $2.4B, with an average return on invested capital of 6.3%.
- Graham intrinsic value
- $22.19
- Share price (Oct 17, 2026)
- $12.34
- Price vs Graham value
- 44% below
- Market cap
- $2.7B
- Revenue (FY2026)
- $2.4B
- Revenue growth (7-yr CAGR)
- 11.9%
- ROIC (10-yr avg)
- 6.3%
- Free cash flow (FY2026)
- —
AVAH 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2026 | $2.4B | $225.0M | $1.05 | — | 10.5% | 21.1% |
| FY2024 | $2.0B | -$10.9M | -$0.06 | — | 6.9% | 6.2% |
| FY2023 | $1.9B | -$134.5M | -$0.71 | — | 0.4% | 0.5% |
| FY2022 | $1.7B | -$117.0M | -$0.00 | -$27.3M | -2.2% | -2.2% |
| FY2021 | $1.5B | -$57.0M | — | $101.4M | -0.2% | -0.3% |
| FY2019 | $1.4B | -$76.5M | — | -$25.4M | 2.8% | 12.7% |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Aveanna Healthcare Holdings, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Aveanna Healthcare Holdings, Inc. has historically struggled to out-earn its cost of capital, averaging just 6.3% ROIC.
Aveanna Healthcare Holdings, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Aveanna Healthcare Holdings, Inc. is modeled at 8.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $22.19 per share.